Tech Inc., the industry’s leading provider of label-free drug
discovery solutions, is pleased to announce that Dr.
Milan Mrksich, founder of SAMDI Tech and professor at Northwestern
University, has been selected to serve as a scientific advisor for SLAS
Technology. A rigorously peer-reviewed, multidisciplinary journal of
for Laboratory Automation and Screening (SLAS), SLAS Technology is
devoted to the advancement of technology for life sciences and
biomedical research and development.
Dr. Mrksich, inventor of the SAMDI technology, joins other elite members
of the scientific community in his service on the advisory board. Over
the course of his five-year term, Dr. Mrksich will advise the journal on
technology trends in the field.
“Milan’s accomplishments are highly regarded in the scientific
community,” said SAMDI Tech CEO Emilio
Córdova, Ph.D., MBA. “His appointment to serve on this advisory
committee reflects his innovation, commitment and leadership. We are
proud he is a part of our team.”
SAMDI (Self-Assembled Monolayer Desorption Ionization) technology was
first described by Dr. Mrksich in 2002 as a solution to the challenges
and pitfalls of label-dependent biochemical assays. Dr. Mrksich found
that self-assembled monolayers (SAMs) could be analyzed by Matrix
Assisted Laser Desorption/Ionization (MALDI) mass spectrometry, a key
discovery that provided the foundation for the label-free and
high-throughput SAMDI assay.
About SAMDI TechSAMDI Tech Inc. delivers better, faster,
label-free assay development, high-throughput screening and peptide
substrate discovery solutions for early-stage drug candidate selection.
Our highly skilled team believes in results and uses proprietary
industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption
Ionization) technology to deliver decision-making data fast. Learn more
about SAMDI Tech at www.samditech.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005188/en/